🇺🇸 FDA
Patent

US 12427151

Compositions and method of treating cancer

granted A61KA61K31/52A61K35/741

Quick answer

US patent 12427151 (Compositions and method of treating cancer) held by The Regents of the University of California expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/52, A61K35/741, A61K45/06, A61K9/0014